Cargando…
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
Tumor immune escape is associated with the loss of tumor HLA class I (HLA-I) expression commonly found in malignant cells. Accumulating evidence suggests that the efficacy of immunotherapy depends on the expression levels of HLA class I molecules on tumors cells. It also depends on the molecular mec...
Autores principales: | Garrido, Federico, Perea, Francisco, Bernal, Mónica, Sánchez-Palencia, Abel, Aptsiauri, Natalia, Ruiz-Cabello, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371743/ https://www.ncbi.nlm.nih.gov/pubmed/28264447 http://dx.doi.org/10.3390/vaccines5010007 |
Ejemplares similares
-
HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape
por: Perea, Francisco, et al.
Publicado: (2017) -
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes
por: Gil-Julio, Hernani, et al.
Publicado: (2021) -
Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of HLA Class I Alterations in Cancer
por: Garrido, Maria Antonia, et al.
Publicado: (2021) -
Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines
por: Rodríguez, Teresa, et al.
Publicado: (2007) -
Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report
por: Cozar, Jose Manuel, et al.
Publicado: (2008)